Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Barinthus Biotherapeutics (BRNS) Return on Assets (2021 - 2025)

Historic Return on Assets for Barinthus Biotherapeutics (BRNS) over the last 5 years, with Q3 2025 value amounting to 0.64%.

  • Barinthus Biotherapeutics' Return on Assets fell 3300.0% to 0.64% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.64%, marking a year-over-year decrease of 3300.0%. This contributed to the annual value of 0.33% for FY2024, which is 200.0% down from last year.
  • As of Q3 2025, Barinthus Biotherapeutics' Return on Assets stood at 0.64%, which was down 3300.0% from 0.51% recorded in Q2 2025.
  • Barinthus Biotherapeutics' 5-year Return on Assets high stood at 0.03% for Q3 2022, and its period low was 0.64% during Q3 2025.
  • Its 5-year average for Return on Assets is 0.25%, with a median of 0.26% in 2021.
  • Per our database at Business Quant, Barinthus Biotherapeutics' Return on Assets surged by 2000bps in 2022 and then plummeted by -3600bps in 2023.
  • Quarter analysis of 5 years shows Barinthus Biotherapeutics' Return on Assets stood at 0.18% in 2021, then soared by 111bps to 0.02% in 2022, then plummeted by -1795bps to 0.33% in 2023, then decreased by -6bps to 0.35% in 2024, then crashed by -81bps to 0.64% in 2025.
  • Its Return on Assets stands at 0.64% for Q3 2025, versus 0.51% for Q2 2025 and 0.43% for Q1 2025.